Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer ’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study

Dementia is a prevalent non-motor manifestation among individuals with advanced Parkinson ’s disease (PD). Glial fibrillary acidic protein (GFAP) is an inflammatory marker derived from astrocytes. Research has ...

Source: Journal of Neuroinflammation - July 20, 2023 Category: Neurology Authors: Tingting Liu, Hongzhou Zuo, Di Ma, Dan Song, Yuying Zhao and Oumei Cheng Tags: Research Source Type: research